Additional European Equity News

AstraZeneca (AZN LN) - Imfinzi plus Imjudo demonstrated unprecedented overall survival in advanced liver cancer with one in five patients surviving five years in HIMALAYA Phase III trial. (AstraZeneca)

Babcock (BAB LN) – Co. is reportedly considering a potential bid for some of the assets of Harland and Wolff, via Sky News citing sources. (Sky News)

Darktrace (DARK LN) - All of the conditions relating to regulatory and antitrust approvals have now been satisfied. (Newswires) 

European Banks – European governments have offloaded over EUR 16bln of bailed-out bank stocks in the past year, according to FT analysis. (FT)

Legal & General (LGEN LN) – Sixth Street is reportedly the frontrunner to purchase Cala Group, the housebuilding subsidiary of Legal & General, via Sky News citing sources; valued at between EUR 1.2-1.3bln. (Sky News)

Phoenix (PHNX LN) - 2024 Interim results: On track to deliver financial targets and create shareholder value. Declared interim dividend which is a 2.5% Y/Y increase. (Newswires) 

Stellantis (STLAM IM/STLAP FP) - Co. is pushing back against any move by the European Union to delay emissions targets set to take effect next year, via AFP. (AFP)

TI Fluid (TIFS LN) – Co. has received at least two offers from ABC Technologies, via Sky News citing sources; the second offer was reportedly at GBP 1.80/shr. A source cited said the Chairman was unlikely to consider a proposal unless it is closer to GBP 2.00/shr. (Sky News) Co. closed at GBP 145.80/shr on Friday

Ipsen (IPN FP) upgraded to Outperform from Sector Perform at RBC

Sandoz (SDZ SW) downgraded to Sector Perform from Outperform at RBC